VIPER Group News

Nicole is presenting at the UK Clinical Vaccine Network Conference on “Evidence-based vaccination policies: Maximizing the role of clinical trials and epidemiologic studies in public health decision-making”

Neeta successfully passed her PhD oral preliminary exam and is officially a PhD candidate! Congrats, Neeta!!

Nicole is attending the Canadian Immunization Research Network (CIRN) Annual General Meeting in Toronto.

Nicole recently hosted the first episode of season 2 of the Sabin Vaccine Institute’s “Getting to Zero” series. She interviewed renowned global health expert Professor Sir Brian Greenwood about his experience working on malaria vaccines and malaria prevention over the past 50 years. Check it out!

Nicole was awarded the Fall 2024 Excellence in Teaching Award for her course EPIB 677 “Vaccine Epidemiology" by the McGill Epidemiology, Biostatistics, and Occupational Health Student Society (EBOSS).

Nicole presented a talk titled “Global Landscape of Meningococcal Vaccination Policies and Practices” during the “Round Table on the WHO Global Road Map to Defeat Meningitis by 2030” at the International Pathogenic Neisseria Conference (IPNC) in Florence, Italy.

Wishing all the best to Yang and Angie who are wrapping up their research assistantships this month!

Ola, Yang, and Nicole’s manuscript “Reporting of Trial Registration Numbers in Publications of Vaccine Randomized Clinical Trials” is now out in JAMA Network Open. Check it out!

Welcome to Chrissa, Lisa and Eva who joined the VIPER team as research assistants!

Wishing all the best to Zuofu, Neeta, and Tiankai who are wrapping up their research assistantships this month!

Congratulations to Nicole on receiving The 2024 Rising Star Award from the Sabin Vaccine Institute!

Wishing all the best to Ola who is wrapping up her research assistantship this month!

The Basta Lab has moved to Montreal! Nicole joined the faculty as an Associate Professor in the Department of Epidemiology, Biostatistics, and Occupational Health at McGill University.